Some people might question why now, but if a company wants to get approval for a trial it needs to show it has the funds to complete it.
Column 1 1 Proceeds from the Placement will be used to:- fund further clinical development of OPT-302 as a therapy for wet Age-related Macular Degeneration (“wet AMD” or “wAMD” through commencement of two concurrent Phase 3 pivotal registrational trials in approximately 660 wet AMD patients each; and- manufacture sufficient quantities of clinical grade OPT-302 for Phase 3 clinical development
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea Raises A$50 million in Institutional Placement
Ann: Opthea Raises A$50 million in Institutional Placement, page-3
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
34.5¢ |
Change
0.005(1.47%) |
Mkt cap ! $376.5M |
Open | High | Low | Value | Volume |
34.0¢ | 35.0¢ | 33.5¢ | $986.8K | 2.875M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 55705 | 34.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 29727 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 55705 | 0.345 |
10 | 234566 | 0.340 |
14 | 729608 | 0.335 |
12 | 265201 | 0.330 |
7 | 303294 | 0.325 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 29727 | 1 |
0.355 | 17096 | 2 |
0.360 | 38996 | 3 |
0.365 | 45000 | 1 |
0.370 | 174576 | 2 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |